| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 76, 64-69, Copyright © 1993 by Endocrine Society
ARTICLES |
Y Hayashi, OE Janssen, RE Weiss, Y Murata, H Seo and S Refetoff
Department of Medicine, University of Chicago, Illinois 60637.
Generalized resistance to thyroid hormone (GRTH), is a syndrome of reduced tissue responsiveness to thyroid hormone. So far, mutations linked to GRTH have been only detected in the hormone-binding domain of the human thyroid hormone receptor (hTR)-beta gene. Although there is no doubt that these mutations result in abnormal hTRs, there is a conspicuous lack of correlation between the severity of clinical manifestations and the degree of functional impairment of the mutant hTRs. In this work we examined whether variable expression of mutant genes relative to the normal genes could explain the observed discrepancies. The relative amounts of mutant and normal hTR beta and normal hTR alpha messenger RNAs in fibroblasts from normal subjects and those from individuals with GRTH were estimated by coamplification of their complementary DNA products. Heterozygous subjects with GRTH from two families manifesting differences in the severity of clinical manifestations expressed equally both normal and mutant hTR beta alleles. Furthermore, there was no compensatory increase in the expression of the normal hTR alpha gene in these individuals nor in fibroblasts from members of a third family with homozygous deletion of the hTR beta gene. In vitro treatment with thyroid hormone did not affect the results. It is concluded that the apparent discrepancies between the functional impairment of the mutant hTRs and the clinical manifestations of GRTH are not due to quantitative differences in the expression of the normal or mutant hTR genes but more likely to variations in the interactions of the mutant hTRs with the normal hTR beta, hTR alpha and nuclear stabilization factors.
This article has been cited by other articles:
![]() |
M. Alonso, C. Goodwin, X. Liao, D. Page, S. Refetoff, and R. E. Weiss Effects of Maternal Levels of Thyroid Hormone (TH) on the Hypothalamus-Pituitary-Thyroid Set Point: Studies in TH Receptor {beta} Knockout Mice Endocrinology, November 1, 2007; 148(11): 5305 - 5312. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mamanasiri, S. Yesil, A. M. Dumitrescu, X.-H. Liao, T. Demir, R. E. Weiss, and S. Refetoff Mosaicism of a Thyroid Hormone Receptor-{beta} Gene Mutation in Resistance to Thyroid Hormone J. Clin. Endocrinol. Metab., September 1, 2006; 91(9): 3471 - 3477. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Pohlenz, R. E. Weiss, P. E. Macchia, S. Pannain, I. T. Lau, H. Ho, and S. Refetoff Five New Families with Resistance to Thyroid Hormone not Caused by Mutations in the Thyroid Hormone Receptor {beta} Gene J. Clin. Endocrinol. Metab., November 1, 1999; 84(11): 3919 - 3928. [Abstract] [Full Text] |
||||
![]() |
R. E. Weiss and S. Refetoff Editorial: Treatment of Resistance to Thyroid Hormone--Primum Non Nocere J. Clin. Endocrinol. Metab., February 1, 1999; 84(2): 401 - 404. [Full Text] |
||||
![]() |
R. E. Weiss, Y. Murata, K. Cua, Y. Hayashi, H. Seo, and S. Refetoff Thyroid Hormone Action on Liver, Heart, and Energy Expenditure in Thyroid Hormone Receptor {beta}-Deficient Mice Endocrinology, December 1, 1998; 139(12): 4945 - 4952. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. Weiss, D. Forrest, J. Pohlenz, K. Cua, T. Curran, and S. Refetoff Thyrotropin Regulation by Thyroid Hormone in Thyroid Hormone Receptor {beta}-Deficient Mice Endocrinology, September 1, 1997; 138(9): 3624 - 3629. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-G. Zhu, P. McPhie, and S.-y. Cheng Differential Sensitivity of Thyroid Hormone Receptor Isoform Homodimers and Mutant Heterodimers to Hormone-Induced Dissociation from Deoxyribonucleic Acid: Its Role in Dominant Negative Action Endocrinology, April 1, 1997; 138(4): 1456 - 1463. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Miyazaki, Y. Kanou, Y. Murata, S. Ohmori, T. Niwa, K. Maeda, H. Yamamura, and H. Seo Molecular Cloning of a Novel Thyroid Hormone-responsive Gene, ZAKI-4, in Human Skin Fibroblasts J. Biol. Chem., June 14, 1996; 271(24): 14567 - 14571. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Brent The Molecular Basis of Thyroid Hormone Action N. Engl. J. Med., September 29, 1994; 331(13): 847 - 853. [Full Text] |
||||
![]() |
A. Dace, L. Zhao, K. S. Park, T. Furuno, N. Takamura, M. Nakanishi, B. L. West, J. A. Hanover, and S.-y. Cheng Hormone binding induces rapid proteasome-mediated degradation of thyroid hormone receptors PNAS, August 1, 2000; 97(16): 8985 - 8990. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |